• Home Interface Controller

    Sunstein has prosecuted a portfolio of patents devoted to the emerging industry of interactive television. Our client ICTV has developed technology that enables cable television subscribers to receive video programming that allows them to interact with their television to play games, videos and music on demand; browse news, sports and weather; and view targeted interactive advertising.

  • Molecular Diagnostic System

    We obtained the patent for Source Precision Medicine’s molecular diagnostic system that measures cellular gene expression with significant precision to assess and track an individual’s current health, disease status and response to drug therapy, potentially a foundation for the future practice of medicine.

  • Acoustic Analysis of Bone

    Patents prosecuted by Sunstein protect technologies, including transient signal processing techniques developed by the Metra Biosystems division of Quidel Corp., that are used in compact ultrasonic devices to measure bone density as an aid in detecting osteoporosis.

  • Magnetization Technology

    Sunstein successfully negotiated a multi-million dollar settlement on behalf of Comair Rotron, following a jury verdict that our client’s patent was infringed. The patent was directed to important magnetization technology for brushless DC electric motors.

Winning at IPRs

Samsung Electronics Co., Ltd. v. Arendi S.A.R.L.

Samsung attacked our client’s patent in the Patent Trial and Appeal Board (PTAB) on grounds of obviousness. We persuaded the PTAB that an element of the claims was not disclosed by the cited references and thus prevented the inter partes review from even being instituted.

Motorola Mobility LLC, Google Inc., and Apple Inc. v. Arendi S.A.R.L.

Motorola, Google and Apple attacked the same patent as Samsung raising several additional grounds. Our arguments carried the day and the inter partes review was not instituted, freeing our client’s patent for unfettered assertion in court.

Apple Inc., Google Inc. and Motorola Mobility LLC v. Arendi S.A.R.L.

In three petitions, attacks were launched against two additional patents on approximately fourteen different grounds and six primary references. Our Preliminary Response arguments eliminated ten grounds and three of the references. The inter partes reviews will go forward only on those that remain.

Spotlight on Patents

diagram1For our client Dr. Leslie Stern of Fall River, Massachusetts, we recently obtained US Patent No. 8,460,310, describing a medical device for use in minimally invasive spine surgery.

In the News

  • 14 SUNSTEIN lawyers named to the 2014 Super Lawyers and Rising Stars lists.

  • Congratulations to our pro bono client GoodWeave and its founder, Kailash Satyarthi, on Mr. Satyarthi’s receipt of the 2014 Nobel Peace Prize. More. . .

  • Steven Saunders is on the faculty for the course “How to Become a Successful Physician Inventor.”

  • We delivered a win for our client American Science and Engineering in an interference proceeding against Rapiscan Systems.  More. . .

  • Lisa Tittemore has been selected as one of the Women Leaders in Law and will be recognized this Fall in Fortune Magazine.

  • Bruce Sunstein was honored to be invited, along with some of America’s foremost entrepreneurial leaders, to the President of the Republic of Korea’s “Leaders’ Meeting for a Creative Economy.”

  • Lisa Tittemore and Joel Leeman have published Protecting and Enforcing Copyright, intended for non-specialist attorneys.

Our Latest Thinking

  • With its decision in Alice Corp., the Supreme Court persists with its ever-narrowing definition of patent-eligible subject matter. The lack of effective guidance on eligibility threatens to harm the patent system. More...
  • The Supreme Court protects TV broadcasters from Aereo’s attempted end-run around the copyright laws. Despite supplying individual antennae to its customers, Aereo is found to have made impermissible “public performance” of protected content. More...
  • The Supreme Court restores an old rule: Liability for inducing infringement of a patented method cannot be imposed unless a single actor performs all steps of the method. More...
  • The bar has been lowered for invalidating a patent on the basis of indefiniteness. The Supreme Court says a challenger must show only that the scope of the invention is not defined with “reasonable certainty.” More...
  • The FTC targets exclusive licenses in the pharmaceutical industry for antitrust scrutiny. A federal court upholds the agency’s power to do so. More...

Free Subscription

See more in Publications/News